Ontunisertib

N/A

Report date: 2026/03/12 20:00:16
NME

Base Information

Drug NameOntunisertib
Drug Alias NameORG-129AGMB-129
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransforming growth factor beta receptor 1 inhibitors
TargetsTransforming growth factor beta receptor 1
Therapy Area/IndicationsCrohn Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[9] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOrigo Biopharma Sociedad Litmitada
China Registration ClassN/A

Develop Information

Active CompaniesAgomab Spain SLUAgomAb Therapeutics NVOrigo Biopharma Sociedad Litmitada
Inactive CompaniesN/A
Active IndicationsCrohn Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A